Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2935 of 5804
-
Can a simple blood test decide when heart failure patients go home?
Knowledge-focused Recruiting nowThis is a multi-centre, single blind, randomized study. Patients admitted to hospital with acute decompensated heart failure will be randomized to biomarker guided discharge algorithm vs usual care in a 2:1 ratio. NTproBNP and other biomarkers will be measured within 24 hours of …
Phase: NA • Sponsor: Ottawa Heart Institute Research Corporation • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Cancer drug capmatinib gets extended safety check in ongoing study
Disease control OngoingThe purpose of this study is to assess long-term safety and provide continued study treatment access to eligible participants who are judged by the Investigator to benefit from continued treatment with capmatinib monotherapy or in combination with other treatments or with the com…
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Your DNA could determine which heart drug works best
Knowledge-focused CompletedThe purpose of this investigation is to evaluate when genetic variation in the carboxylesterase 1 (CES1) gene influences antiplatelet therapy response, as assessed by ex vivo platelet aggregometry, in healthy participants treated with clopidogrel and ticagrelor. We hypothesize th…
Phase: PHASE4 • Sponsor: University of Maryland, Baltimore • Aim: Knowledge-focused
Last updated Jul 26, 2026 00:00 UTC
-
Promising drug combo targets tough leukemia in early trial
Disease control CompletedThis phase I trial studies the side effects and best dose of pevonedistat when given together with decitabine in treating patients with high risk acute myeloid leukemia. Pevonedistat and decitabine may stop the growth of cancer cells by blocking some of the enzymes need for cell …
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Can a drug combo heal breathing tube damage to the voice box?
Disease control OngoingThe purpose of this investigation is to delineate the incidence of acute and chronic laryngeal injury following intubation within our health system. In addition, this study seeks to identify risk factors for airway injury that may provide information to help reduce the incidence …
Phase: PHASE1, PHASE2 • Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New liposomal drug shows promise for Hard-to-Treat cancers
Disease control OngoingThe maximum tolerated dose (MTD) of E7389 liposomal formulation (E7389-LF) will be determined in the dose escalation part. Safety, pharmacokinetics (PK) and efficacy will be assessed using treatment regimen evaluated in dose escalation part in participants with breast cancer (up …
Phase: PHASE1 • Sponsor: Eisai Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Sleep sounds may quiet seizures
Symptom relief OngoingThe objective of this study is to test the feasibility and physiological effect of low-frequency (1 Hz) acoustic stimulation delivered during nocturnal NREM sleep in epilepsy patients. The long-term goal is to develop this protocol for daily, long-term use in a home setting, for …
Phase: NA • Sponsor: NYU Langone Health • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
Experimental cancer combo aims to supercharge immune attack on tumors
Disease control OngoingThis phase I trial aims to investigate a potential enhancement of IMP321 immune-activating effects by new routes of administration: direct injection of IMP321 into the tumor tissue; intra-peritoneal therapy; combination of chemotherapy and/or immunotherapy/targeted therapy with a…
Phase: PHASE1 • Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New radiation approach shows promise for mesothelioma patients
Disease control OngoingThis is a monocentric prospective study of radiotherapy using accelerated hypofractionation with Tomotherapy in Malignant Pleural Mesothelioma (MPM) patients after pleurectomy / decortication (P / D) or biopsy. The treatment will be delivered using Tomotherapy, that allows to ad…
Phase: NA • Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Blood cell collection could open door to CAR T-Cell therapy for leukemia and lymphoma patients
Knowledge-focused ENROLLING_BY_INVITATIONBackground: Leukapheresis is a procedure to separate and collect white blood cells. It is the first step in a treatment called CAR (chimeric antigen receptor) T-cell therapy. CAR-T therapy may be offered to people when their cancer comes back. The collected T-cells are used to m…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC
-
Parent training shows promise for easing ADHD symptoms in young kids
Symptom relief CompletedThis study evaluates the efficacy of the Nurtured Heart Approach (NHA) to reduce inattention and hyperactivity and impulsivity in children ages 6 - 8 years. Participants are parents or guardians of children diagnosed with, or suspected of, attention deficit hyperactivity disorder…
Phase: NA • Sponsor: University of Arizona • Aim: Symptom relief
Last updated Jun 27, 2026 08:06 UTC
-
Simple nerve stretches may ease arm pain after breast cancer surgery
Symptom relief CompletedObjective: To determine whether adding neurodynamic mobilization to early postoperative physiotherapy improves long-term shoulder disability after breast cancer surgery with axillary lymph node dissection. Design: prospective randomized and single blind trial where participants w…
Phase: NA • Sponsor: University of Alcala • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
Omega-3s tested as breast cancer shield in new trial
Prevention OngoingThe study aims to determine biological changes associated with a low vs high dose of omega 3 fatty acids, docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), over 12 months in women at risk for recurrent breast cancer. The objectives of the trial are to develop mammary epith…
Phase: NA • Sponsor: City of Hope Medical Center • Aim: Prevention
Last updated Jun 27, 2026 12:03 UTC
-
Can exercise plus metformin boost heart health? new study investigates
Disease control CompletedHealth organizations recommend exercise in an intensity based manner to promote cardiovascular adaptation and prevent disease. Metformin is a common anti-diabetes medication that reduces future type 2 diabetes and cardiovascular disease (CVD) risk. However, the optimal dose of ex…
Phase: PHASE2, PHASE3 • Sponsor: Rutgers University • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Immunotherapy combo shows promise in early ovarian cancer trial
Disease control CompletedThe purpose of this study is to find out what effects, good or bad, the addition of nivolumab or the combination of nivolumab plus ipilimumab to typical chemotherapy has on the treatment of advanced high-grade serous cancers of ovarian, fallopian tube, or primary peritoneal origi…
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New study aims to stop early life support withdrawal in cardiac arrest patients
Knowledge-focused Recruiting nowCardiovascular disease remains the leading cause of death in the United States. Mortality rates of cardiac arrest range from 60-85%, and approximately 80% of survivors are initially comatose. Of those who survive, 50% are left with a permanent neurological disability, and only 10…
Sponsor: Boston Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC
-
Bright light therapy shows promise for Veterans' sleep troubles
Symptom relief Recruiting nowOne of the principal complicating factors associated with traumatic brain injury (TBI) is sleep-wake disturbances (e.g., insomnia, excessive daytime sleepiness, and circadian rhythm sleep disorders). Morning bright light therapy (MBLT) has been shown to improve sleep quality in a…
Phase: NA • Sponsor: Portland VA Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 07:57 UTC
-
Shock therapy for leg pain? tiny device may help PAD patients move more
Symptom relief CompletedPeripheral Arterial disease is a common condition which causes narrowing of the arteries. The most common symptom that patients with PAD experience is Intermittent Claudication (IC), pain in the lower limb(s) on exertion, which is relieved by rest. IC reduces patients' quality of…
Phase: NA • Sponsor: Glasgow Caledonian University • Aim: Symptom relief
Last updated Jun 27, 2026 07:53 UTC
-
Urine test may reveal which prostate cancers are truly dangerous
Knowledge-focused Recruiting nowThrough a better understanding of the biology of significant (lethal) prostate cancer, we hope to develop new markers/targets from urine metabolomics for more effective screening and prevention of significant prostate cancer. In the meantime, with these new markers we may substan…
Phase: NA • Sponsor: National Taiwan University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC
-
New pill shows promise for Hard-to-Treat cancers in early trial
Disease control OngoingThis study will be conducted to assess the safety/tolerability profile of E7386 as a single agent administered orally in participants with selected advanced or recurrent neoplasms and to determine the maximum tolerated dose (MTD) and/or recommended Phase 2 dose (RP2D) of E7386.
Phase: PHASE1 • Sponsor: Eisai Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC